MB BChir

MB BChir

The degree granted by some medical schools in the UK, which is equivalent to MB BS, but incorrectly suggests that there are two degrees; the equivalent in many countries is MD (medical doctor), a title which in the UK is conferred upon a person who completed medical school with honours, as well as one or more additional years of study.
References in periodicals archive ?
Addressing the significant unmet need in fibrotic diseases is a key part of Bristol-Myers Squibbs strategy to build a sustainable and diversified portfolio of transformational medicines, said Francis Cuss, MB BChir, FRCP, executive vice president and chief scientific officer of Bristol-Myers Squibb.
Effective immediately, Dr Namouni will be responsible for the execution of a comprehensive development strategy for the company's robust oncology pipeline,remain a member of the R&D leadership team as well as continue to report to its executive vice president, chief scientific officer, Francis Cuss, MB Bchir, FRCP.
Niall Moore, MA, MB BChir, FRCR, FRCP, is Associate Professor of Radiology, X-Ray Department, John Radcliffe Hospital, Headley Way, Headington, United Kingdom.
He will report to Francis Cuss, MB BChir, FRCP, senior vice president, Research, R&D, Bristol-Myers Squibb, and will be a member of the Research Senior Leadership Team.
At Bristol-Myers Squibb, patients are the inspiration behind our pioneering research in the field of Immuno-Oncology, which has led to the approval of novel agents for the treatment of some of the hardest to treat cancers,' said Francis Cuss, MB BChir, FRCP, executive vice president and chief scientific officer, Bristol-Myers Squibb.
Francis Cuss, MB BChir, FRCP, executive vice president and chief scientific officer, Bristol-Myers Squibb, said, Bristol-Myers Squibb is committed to leading scientific advances in immuno-oncology and our acquisition of Flexus will expand our innovative pipeline with an important approach to enhancing immune responses in cancer.
The FALCON study has the potential to impact clinical practice concerning endocrine treatment options for women with hormone receptor positive locally advanced or metastatic breast cancer," said Matthew Ellis, MB BChir PhD, Professor of Medicine, Washington University School of Medicine and Siteman Cancer Center Breast Cancer Program.
Francis Cuss, MB BChir, FRCP, executive vice president and chief scientific officer, Bristol-Myers Squibb, stated : "Delivering innovative medicines that halt or slow the progression of fibrotic diseases is a key part of our R&D strategy to build a sustainable pipeline, said .
Francis Cuss, MB BChir, FRCP, executive vice president and chief scientific officer at Bristol-Myers Squibb, said, 'Bristol-Myers Squibb's collaboration with DCRI reflects our commitment to providing broader, more timely access to important clinical trial information and serves as a catalyst to strengthening public confidence in medicines, advancing science and improving public health.
At Bristol-Myers Squibb we are dedicated to discovering and developing medicines that address serious unmet need," said Francis Cuss, MB BChir, FRCP, senior vice president for Research at Bristol-Myers Squibb.